Nvwm LLC Increases Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Nvwm LLC increased its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 96.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,493 shares of the financial services provider’s stock after purchasing an additional 733 shares during the quarter. Nvwm LLC’s holdings in iShares Biotechnology ETF were worth $197,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Darwin Wealth Management LLC acquired a new position in shares of iShares Biotechnology ETF in the 3rd quarter valued at about $29,000. Highline Wealth Partners LLC acquired a new position in iShares Biotechnology ETF in the third quarter valued at approximately $30,000. HHM Wealth Advisors LLC lifted its holdings in iShares Biotechnology ETF by 200.0% in the fourth quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock valued at $30,000 after acquiring an additional 150 shares during the period. Ashton Thomas Securities LLC purchased a new stake in iShares Biotechnology ETF in the 3rd quarter worth approximately $36,000. Finally, Hager Investment Management Services LLC acquired a new stake in shares of iShares Biotechnology ETF during the 4th quarter worth approximately $34,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 2.5 %

IBB opened at $142.33 on Thursday. The firm has a fifty day moving average price of $136.31 and a 200 day moving average price of $141.47. iShares Biotechnology ETF has a 1 year low of $123.60 and a 1 year high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The firm also recently declared a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were issued a $0.0624 dividend. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.